Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies

BACKGROUND: Health-related quality of life (HRQoL) may be markedly impaired in patients with moderate-to-severe psoriasis. OBJECTIVES: Our objectives were to compare improvements in Dermatology Life Quality Index (DLQI) and Psoriasis Symptoms and Signs Diary (PSSD) scores between patients receiving...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Clin Dermatol
Autors principals: Armstrong, April W., Reich, Kristian, Foley, Peter, Han, Chenglong, Song, Michael, Shen, Yaung-Kaung, You, Yin, Papp, Kim A.
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2018
Matèries:
Original Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513809/
https://ncbi.nlm.nih.gov/pubmed/30417277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40257-018-0396-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars